Literature DB >> 30448339

The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease.

James M FitzGerald1, Gayan Perera2, Alexandra Chang-Tave2, Annabel Price3, Anto P Rajkumar4, Manorama Bhattarai5, John T O'Brien3, Clive Ballard6, Dag Aarsland7, Robert Stewart4, Christoph Mueller8.   

Abstract

OBJECTIVES: To describe the incidence of delirium recording before and after a diagnosis of dementia is established in patients with dementia with Lewy bodies (DLB) and compare findings to a matched cohort of patients with Alzheimer's disease (AD).
DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: A cohort of patients with dementia from a large mental health and dementia care database in South London, linked to hospitalization and mortality data. We identified 194 patients with DLB and 1:4 matched these with 776 patients diagnosed with AD on age, gender, and cognitive status. MEASURES: We identified delirium episodes recorded in mental health and hospital records from 1 year before to 1 year after dementia diagnosis. Using dementia diagnosis as an index date we additionally followed patients until first episode of delirium, death or a censoring point without restricting the observation period.
RESULTS: Patients with DLB had significantly more episodes of delirium recorded in the year before dementia diagnosis than patients with AD (incidence rate 17.6 vs 3.2 per 100 person-years; P < .001). Whereas the incidence of recording of delirium episodes reduced substantially in patients with DLB after dementia diagnosis, it remained significantly higher than in patients with AD (incidence rate 6.2 vs 2.3 per 100 person-years; P = .032). Cox regression models indicate that patients with DLB remain at a higher risk of delirium than patients with AD after a dementia diagnosis. CONCLUSIONS/RELEVANCE: Establishing a diagnosis of dementia reduces episodes classified as delirium in patients with DLB and might lead to fewer potentially harmful interventions such as hospitalization or use of antipsychotic medication.
Copyright © 2018 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Delirium; dementia; dementia with Lewy bodies; hospitalization

Mesh:

Year:  2018        PMID: 30448339     DOI: 10.1016/j.jamda.2018.09.021

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  6 in total

1.  Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer's Coordinating Center.

Authors:  Sarah Payne; Jane B Shofer; Andrew Shutes-David; Ge Li; Adrienne Jankowski; Pamela Dean; Debby Tsuang
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Dementia with Lewy bodies.

Authors:  Emma Vardy
Journal:  Clin Med (Lond)       Date:  2019-09       Impact factor: 5.410

3.  Prevalence and risk factors of postoperative delirium after spinal surgery: a meta-analysis.

Authors:  Hua Gao; Hui-Juan Ma; Ying-Jia Li; Ci Yin; Zheng Li
Journal:  J Orthop Surg Res       Date:  2020-04-09       Impact factor: 2.359

4.  Delirium-Onset of Prodromal Dementia With Lewy Bodies-Putative Brainstem-Related Pathomechanism and Clinical Relevance.

Authors:  Niels Hansen; Charles Timäus; Caroline Bouter; Claudia Lange; Katharina Packroß
Journal:  Front Aging Neurosci       Date:  2022-02-25       Impact factor: 5.750

5.  Promoting independence in Lewy body dementia through exercise: the PRIDE study.

Authors:  Michael J Inskip; Yorgi Mavros; Perminder S Sachdev; Jeffrey M Hausdorff; Inbar Hillel; Maria A Fiatarone Singh
Journal:  BMC Geriatr       Date:  2022-08-09       Impact factor: 4.070

Review 6.  Research criteria for the diagnosis of prodromal dementia with Lewy bodies.

Authors:  Ian G McKeith; Tanis J Ferman; Alan J Thomas; Frédéric Blanc; Bradley F Boeve; Hiroshige Fujishiro; Kejal Kantarci; Cristina Muscio; John T O'Brien; Ronald B Postuma; Dag Aarsland; Clive Ballard; Laura Bonanni; Paul Donaghy; Murat Emre; James E Galvin; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Lawrence S Honig; Manabu Ikeda; James B Leverenz; Simon J G Lewis; Karen S Marder; Mario Masellis; David P Salmon; John Paul Taylor; Debby W Tsuang; Zuzana Walker; Pietro Tiraboschi
Journal:  Neurology       Date:  2020-04-02       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.